SEC Info - Foamix Pharmaceuticals Ltd. - ‘F-1MEF’ on 4/14/15

SEC Info℠

Home

Help

Please Sign In

Foamix Pharmaceuticals Ltd. – ‘F-1MEF’ on 4/14/15 – EX-23.1

On: Tuesday, 4/14/15, at 7:04pm ET · Effective: 4/14/15 · Accession #: 1567619-15-496 · File #s: 333-203187, 333-203413

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/14/15  Foamix Pharmaceuticals Ltd.       F-1MEF      4/14/15    3:72K                                    Summit Fin’l Pri… LLC/FA

Registration of Additional Securities — Form F-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-1MEF      Registration of Additional Securities               HTML     42K 
 2: EX-5.1      Opinion re: Legality                                HTML     10K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      6K

EX-23.1 — Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form F-1 of our report dated March 17, 2015, relating to the consolidated financial statements, which appears in Foamix Pharmaceuticals Ltd.’s Annual Report on Form 20-F for the year ended December 31, 2014. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

		/s/*Kesselman & Kesselman*
Tel Aviv, Israel		Kesselman & Kesselman
April 14, 2015		Certified Public Accountants (Isr.)
		A member firm of PricewaterhouseCoopers International Limited

Dates Referenced Herein and Documents Incorporated by Reference

This ‘F-1MEF’ Filing	Date	Other Filings

Filed on / Effective on:	4/14/15
	3/17/15	20-F
	12/31/14	20-F
		List all Filings

↑Top

Filing Submission 0001567619-15-000496 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)